Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier BV in Biological Psychiatry
- Vol. 55 (5), 452-456
- https://doi.org/10.1016/j.biopsych.2003.09.012
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Glycine Tranporter-1 Blockade Potentiates NMDA-Mediated Responses in Rat Prefrontal Cortical Neurons In Vitro and In VivoJournal of Neurophysiology, 2003
- Direct Calcium Binding Results in Activation of Brain Serine RacemaseJournal of Biological Chemistry, 2002
- Glutamatergic Mechanisms in SchizophreniaAnnual Review of Pharmacology and Toxicology, 2002
- Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant SchizophreniaThe British Journal of Psychiatry, 1996
- Cloning and expression of a glycine transporter reveal colocalization with NMDA receptorsNeuron, 1992
- Physiological and pathophysiological roles of excitatory amino acids during central nervous system developmentBrain Research Reviews, 1990
- Assessing Normality in Random Effects ModelsThe Annals of Statistics, 1989
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960